Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Abaxis To Report Second Quarter Fiscal Year 2014 Financial Results Tuesday, October 22, 2013

 Abaxis To Report Second Quarter Fiscal Year 2014 Financial Results Tuesday,
                               October 22, 2013

PR Newswire

UNION CITY, Calif., Oct. 14, 2013

UNION CITY, Calif., Oct. 14, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS:
ABAX), a medical products company manufacturing point-of-care blood
instrumentation and consumables to the medical, research and veterinary
markets, has scheduled a conference call to discuss its financial results for
the second quarter fiscal year 2014, ended September 30, 2013. The call will
be at 4:15 p.m. ET on Tuesday, October 22, 2013.  The Company will report
financial results for the second quarter fiscal year 2014 after the market
closes on Tuesday, October 22, 2013.

Participants can dial (877) 317-6789 or (412) 317-6789 to access the
conference call, or can listen via a live Internet web cast, which is
available in the Investor Relations section of the Company's website at A replay of the call is available by visiting
for the next 30 days or by calling (877) 344-7529 or (412) 317-0088,
confirmation code 10035233, through October 28, 2013.

About Abaxis

Abaxis develops, manufactures, markets and sells portable blood analysis
systems for use in any veterinary or human patient-care setting to provide
clinicians with rapid blood constituent measurements. The system consists of a
compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the chemicals
required to perform a panel of up to 13 tests on veterinary patients and 14
tests on human patients. The system can be operated with minimal training and
performs multiple routine tests on whole blood, serum or plasma samples. The
system provides test results in less than 12 minutes with the precision and
accuracy equivalent to a clinical laboratory analyzer. The veterinary business
also provides to the animal health and research market a line of hematology
instruments for point-of-care complete blood counts (CBC), a specialty
instrument to screen for and detect clotting disorders and to measure equine
fibrinogen levels, a handheld instrument for the rapid assessment of certain
critical care tests and rapid point-of-care tests for Heartworm infections in
dogs, Parvovirus, Lyme and Giardia.  Abaxis, through its AVRL Division,
provides routine laboratory testing as well as specialty testing for
veterinarians nationwide. For more information, visit

Contact: Clint Severson          Lytham Partners, LLC 
         Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum
         Abaxis, Inc.            602-889-9700

SOURCE Abaxis, Inc.

Sponsored Links
Sponsored Links